Likewise, low levels of circ0025202 affecting the miR-182-5p/FOXO3a axis have been associated with the resistance of one of the most commonly used hormone therapy for hormone receptor (HR)-positive breast cancer patients (tamoxifen). This evidence concerns the gene FOXO3 and breast carcinoma.